Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012

Eurosurveillance

Volumn 17, Issue 12, 2012, Pages

  Jimenez Jorge S ^a,b   de Mateo, S ^a,b   Pozo, F ^c   Casas, I ^c   Garcia Cenoz M ^b,d   Castilla, J ^b,d   Gallardo, V ^e   Perez E ^e   Vega, T ^f   Rodriguez, C ^f   Quinones, C ^g   Martinez E ^g   Gimenez J ^h   Vanrell, J M ^h   Castrillejo, D ⁱ   Serrano, M C ^j   Ramos, J M ^j   Larrauri, A ^a,b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e Servicio de Epidemiología Y Salud Laboral   (Spain)

^f Departamento de Salud Pública   (Spain)

^g General de Salud Publica   (Spain)

^h Servicio de Epidemiologia   (Spain)

ⁱ Hospital Comarcal de Melilla   (Spain)

^j Servicio Extremeno de Salud   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; FLU LIKE SYNDROME; GENETIC ANALYSIS; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; PHYLOGENY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SPAIN; VACCINATION;

EID: 84859086467     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Valenciano M, Ciancio B, Moren A, the influenza vaccine effectiveness working group. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveill. 2008;13(43):pii=19015. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19015
2. World Health Organization (WHO). Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Geneva: WHO; World Health Organization; 18 February 2010 (revised 5 March 2010). Available from:http://www.who.int/influenza/vaccines/virus/recommendations/201002_Recommendation.pdf
3. Spanish Ministry of Health and Social Policy. Prevención de la gripe. Recomendaciones de vacunación antigripal. [Influenza prevention. Recommendations for influenza vaccination]. Spanish. Available from:http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/gripe/home.htm
4. Savulescu C, Jiménez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, et al. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Euro Surveill. 2011;16(11):pii=19820. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19820
5. Savulescu C, Valenciano M, de Mateo S, Larrauri A, the cycEVA Study Team. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine. 2010;28(16):2903-7.
6. Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health. 2011;11:899.
7. Jiménez-Jorge S, Savulescu C, Pozo F, De Mateo S, Casas I, Ledesma J, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine. Forthcoming.
8. European Commission. Commission Decision of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Luxembourg: Publications Office of the European Union. 1.5.2009:L 110/58. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:110:0058:0059:EN:PDF
9. Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology, 3rd ed. Philadelphia: Lippincott-Raven. 2008. Validity in epidemiologic studies. p. 128-47.
10. Instituto de Salud Carlos III. National Centre of Epidemiology. La actividad gripal desciende en España tras alcanzar el pico de la onda epidémica en la semana 07/2012. Semana 08/2012 (20-26 de febrero 2012). [Influenza activity is decreasing in Spain after the epidemic wave peaked in week 07/2012. Week 08/2012 (20-26 February 2012)]. Spanish. Available from: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-gripe/fd-informes-semanales-vigilancia-gripe/grn0812.pdf
11. Instituto de Salud Carlos III. National Centre of Epidemiology. Informe anual de gripe de la temporada 2005-2006. Vigilancia de la gripe en España. Sistema Centinela. [Annual influenza report. Season 2005-2006. Influenza surveillance in Spain. Sentinel System]. Spanish. Available from:http://vgripe.isciii.es/gripe/documentos/20052006/InformesAnuales/Gripe0506.pdf
12. Instituto de Salud Carlos III. National Centre of Epidemiology. Informe anual de gripe de la temporada 2006-2007. Vigilancia de la Gripe en España. Sistema centinela. [Annual influenza report, Season 2006-2007. Influenza surveillance in Spain. Sentinel System]. Spanish. Available from:http://vgripe.isciii.es/gripe/documentos/20062007/InformesAnuales/Informe_Temporada_06-07.pdf
13. Instituto de Salud Carlos III. National Centre of Epidemiology. Informe anual de gripe-Evolución de la gripe pandémica por AnH1N1 (Desde la semana 20/2009 hasta la semana 20/2010). Sistema de Vigilancia de la Gripe en España. [Annual influenza report. Evolution of pandemic influenza by A(H1N1)2009 (from week 20/2009 to week 20/2010). Spanish Influenza Surveillance System]. Spanish. Available from:http://vgripe.isciii.es/gripe/documentos/20092010/InformesAnuales/Informe_anual_temporada_2009-2010.pdf
14. Instituto de Salud Carlos III. National Centre of Epidemiology. Informe anual de gripe de la temporada 2010-2011 (Desde la semana 40/2010 hasta la semana 20/2011). Sistema de Vigilancia de la Gripe en España. [Annual influenza report. Season 2010-2011. Spanish Influenza Surveillance System]. Spanish. Available from:http://vgripe.isciii.es/gripe/documentos/20102011/InformesAnuales/Informe_GRIPE_Temporada_2010-11_07092011.pdf
15. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Geneva: WHO; February 2012. Available from:http://www.who.int/influenza/vaccines/virus/recommendations/201202_recommendation.pdf
16. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Geneva: WHO. [Accessed 22 Mar 2012]. Available from:http://www.who.int/influenza/vaccines/virus/recommendations/recommendations_2011_12north/en/
17. European Centre for Disease Control and Prevention (ECDC). Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe. Influenza virus characterisation. Summary Europe, February 2012. Stockholm: ECDC; Feb 2012. Available from:http://ecdc.europa.eu/en/publications/Publications/1203_TED_CNRL_report_Feb2011.pdf
18. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062-7.
19. Fielding JE, Grant KA, Papadakis G, Kelly HA. Estimation of type-and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. BMC Infect. Dis. 2011;11:170.
20. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect. Dis. 2009;199(2):168-79.
21. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One. 2009;4(3):e5079.
22. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis. 2009;199(2):159-67.
23. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25(39-40):6852-62.
24. Centers for Disease Control and Prevention (CDC). Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep. 2008;57(15):393-8.
25. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One. 2011;6(11):e27622.